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Despite considerable basic research into the mech-
anisms of atrial fibrillation (AF), not much progress
has been made in the prognosis of patients with
AF. With the exception of anticoagulant therapy,
current treatments for AF still do not improve
major cardiovascular outcomes. This may be due
partly to the diverse aetiology of AF with increas-
ingly more factors found to contribute to the
arrhythmia. In addition, a strong increase has
been seen in the technological complexity of the
methods used to quantify the main pathophysio-
logical alterations underlying the initiation and
progression of AF. Because of the lack of standard-
ization of the technological approaches currently
used, the perception of basic mechanisms of AF
varies widely in the scientific community. Areas of
debate include the role of Ca2+-handling alter-
ations associated with AF, the contribution and
noninvasive assessment of the degree of atrial
fibrosis, and the best techniques to identify elec-
trophysiological drivers of AF. In this review, we
will summarize the state of the art of these
controversial topics and describe the diverse
approaches to investigating and the scientific
opinions on leading AF mechanisms. Finally, we
will highlight the need for transparency in scien-
tific reporting and standardization of terminology,
assumptions, algorithms and experimental con-
ditions used for the development of better AF
therapies.
Keywords: atrial fibrillation, Ca2+-handling, fibrosis,
multiple wavelet hypothesis, rotors.
Introduction
Since the 1990s there has been a tremendous
increase in basic research to investigate the mech-
anisms of atrial fibrillation (AF) with increasing
attention from the scientific community in terms of
both allocated resources and scientific output.
While the resulting understanding of the pathome-
chanisms of AF has grown steadily, the major
clinical outcomes of AF patients have improved
only marginally. Antiarrhythmic drug treatment
can often not prevent recurrences of AF. Catheter
ablation, originally developed for treatment of
paroxysmal AF, has a limited efficacy in patients
with persistent AF and anticoagulation therapy,
even since the introduction of the novel oral
anticoagulants, is still associated with potentially
harmful side effects.
The lack of improvement in clinical outcomes in
AF may partially reflect our inability to detect
individual disease mechanisms underlying the
arrhythmia in individual patients. The multifacto-
rial aetiology of AF has been recognized for many
428 ª 2016 The Association for the Publication of the Journal of Internal Medicine
Review
years but so far individual disease mechanisms
cannot be reliably identified by easily accessible
clinical signs and symptoms [1]. Closing this
‘translational gap’ by linking the diverse pathome-
chanisms to sets of phenotypic features in
patients is among the most important challenges
in cardiac research in general and in the field of
AF in particular [2].
Another reason for the slow improvement of current
AF therapies may be related to the complexity of the
basic research related to this field. Very different
and increasingly more sophisticated technological
approaches are being used to unravel basic AF
mechanisms. Definitions, assumptions and algo-
rithms used in these technical approaches vary
widely and have resulted in fundamentally different
perceptions even of very basic mechanisms of AF.
Here, we will provide a brief overview of some of
these controversial areas of AF research. Specifi-
cally, we will discuss the contribution of Ca2+-
handling alterations and the role of atrial fibrosis
in AF as well as the still debated issue of the
prevailing conduction patterns during AF.
Ca2+-handling instability versus Ca2+-signalling silencing
It is likely that the limited efficacy of current
pharmacological treatment options result from an
incomplete understanding of AF pathophysiology.
Focal ectopic firing is required for the initiation of
AF in a vulnerable substrate, but can also maintain
AF when it occurs repetitively at a high frequency.
While reentry is a well-accepted mechanism of AF,
the contribution of ectopic (triggered) activity
caused by delayed afterdepolarizations (DADs),
which depend on abnormalities of Ca2+ handling,
is less clear and somewhat controversial [3].
Recent studies in small and large animal models of
AF have provided evidence for and insights into the
potential molecular basis of DAD-mediated trig-
gered activity. Important roles for ryanodine recep-
tor (RyR2) dysfunction, increased sarcoplasmic
reticulum (SR) Ca2+ leak and spontaneous Ca2+-
release events in pacing-induced AF have been
suggested by the results of experimental studies in
mice lacking the RyR2-stabilizing subunit
FKBP12.6, carrying an E169K mutation in junc-
tophilin-2 or with gain-of-function mutations pre-
disposing to catecholaminergic polymorphic
ventricular tachycardia (CPVT) [4–7]. Pharmaco-
logical inhibition of Ca2+/calmodulin-dependent
protein kinase type-II (CaMKII), genetic inhibition
of CaMKII-dependent RyR2-Ser2814 phosphoryla-
tion and the RyR2-stabilizing compound S107
prevent AF initiation in FKBP12.6 knock-out mice,
also supporting a critical role for RyR2 dysfunction
in AF vulnerability [6–8].
Findings from large animal models of AF also
indicated a role of Ca2+-handling abnormalities in
AF pathophysiology. Dogs with persistent AF show
hyperphosphorylated RyR2 and increased RyR2
open probability [9]. Experimental heart failure
increases SR Ca2+ load and promotes cellular
triggered activity, which involves increased CaMKII
but reduced RyR2 expression with unaltered phos-
phorylation [10]. In goats with persistent AF, SR
Ca2+ uptake is reduced, whereas CaMKII-depen-
dent RyR2 phosphorylation is increased, which is
likely to increase SR Ca2+ leak [11]. Ca2+-handling
abnormalities along with a higher incidence of
DADs also occur in right atrial cardiomyocytes
from patients with persistent AF, suggesting Ca2+-
handling instability in AF patients [12–14].
Increased CaMKII function with subsequent CaM-
KII-dependent RyR2 hyperphosphorylation
appears to play a key role in diastolic SR Ca2+ leak
and cellular triggered activity in patients with
persistent AF [7, 13, 14]. Taken together there is
now compelling evidence in animal models and in
patients for a role of DAD-mediated cellular trig-
gered activity in patients with persistent AF. How-
ever, despite the occurrence of DADs and cellular
triggered activity in human atrial cardiomyocytes
from patients with persistent AF in vitro, it is not
clear whether DADs can also occur during AF
in vivo and, if so, how they contribute to the
fibrillatory process maintaining AF (Fig. 1).
There is evidence froma rabbitmodel that sustained
high atrial activation rates per se do not increase SR
Ca2+ leak despite hyperphosphorylation of theRyR2
[15]. Computational analysis suggested that the
strongly reducedRyR2expression in thismodelmay
offset the effects RyR2 hyperphosphorylation on SR
Ca2+ leak. Ca2+-wave propagation to the myocyte
centre was impaired in both rabbits and patients
with persistent AF, which is likely to be due to an
increase in Ca2+-buffering strength along with a
reduction in intracellular Na+ concentration follow-
ing rapid atrial pacing. Atrial tachycardia remod-
elling in dogs also induces impaired Ca2+-wave
propagation to the cell centre [16]. Together, these
data suggest that sustained high atrial rates per se
may not produce Ca2+-handling instability and
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indicate the possibility that these Ca2+-handling
abnormalities including increased SR Ca2+ leak in
patients with persistent AF might result from the
accompanying cardiovascular diseases rather than
from AF itself. In addition, it appears that once AF
persists the high atrial rate may cause Ca2+-hand-
ling silencing to counteract the potentially cytotoxic
effects of chronically elevated intracellular Ca2+
levels. Therefore, it could be speculated that
depending on the underlying cardiovascular condi-
tions, either proarrhythmic Ca2+-handling abnor-
malities or arrhythmia-suppressing Ca2+-handling
silencing might prevail, highlighting the need for
appropriate substrate classification and tailored
Ca2+-handling targeting in an individual AF patient.
Furthermore, Na+ homeostasis has a very important
impact on the function of various ion channels and
transporters [17]. Findings from experimental mod-
els suggest that atrial tachycardia and AF reduce
Na+ load [15] which, if also the case in human AF,
paradoxically may contribute to Ca2+ depletion and
prolongation of the action potential.
Another inconsistency in the field is the discrep-
ancy between results from experiments in isolated
human atrial cardiomyocytes and in human atrial
trabecular tissue. Although Ca2+-handling insta-
bility has been reported in human atrial myocytes
[14, 18], in human atrial trabeculae spontaneous
activity defined as abnormal aftercontractions is
less common in tissue from patients with AF as
compared to those in sinus rhythm [19]. These
results may be due to the fact that the Na+
concentration in isolated myocytes is altered by
the concentration of the ion in the patch pipette,
which is not the case in atrial trabeculae. Further
work is needed to specifically address this impor-
tant but underinvestigated area.
It could be speculated that during AF instead of
contributing to DAD development the persistent SR
Ca2+ leak may initiate Ca2+-dependent pathways,
thereby contributing to the remodelling process that
promotes the transition of AF to more persistent
forms of AF. Evidence supporting such a concept
was provided by Li et al. [20] in studies in mice with
cardiac-restricted overexpression of a repressor
form of the cAMP response element modulator
(CREM-TG mice), which exhibit atrial dilatation,
abnormal cardiomyocyte growth, mild atrial fibro-
sis, reduced expression of connexin-40 and Ca2+-
handling abnormalities including increased SR
Ca2+ leak. CaMKII-dependent hyperphosphoryla-
tion of the RyR2 and SR Ca2+ leak are likely to be
early events in the spontaneous development of AF
in CREM-TG mice, because spontaneous AF is
eliminated when these animals are crossed with
RyR2-S2814A-TGmiceresistanttoCaMKII-dependent
Fig. 1 Molecular determinants of the generation of delayed after depolarization (DAD) and cellular triggered activity in
patients with paroxysmal and chronic atrial fibrillation (AF). Red upward and downward arrows indicate factors that are
increased or decreased in AF patients, respectively. Question marks indicate areas of uncertainty that need to be further
studied. JNC-2, junctophilin-2; RyR2, ryanodine receptor; CaMKII, Ca2+/calmodulin-dependent protein kinase type-II; NCX,
Na+/Ca2+-exchanger; SERCA2a, SR Ca2+-ATPase. See main text for further details.
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RyR2 hyperphosphorylation. In addition, these
authors demonstrated that the development of AF
substrate was directly linked to excess RyR2-
mediated SR Ca2+ leak and that excess RyR2-
mediated SR Ca2+ leak in CREM-TG mice stimu-
lated the calcineurin–NFAT pathway associated
with atrial dilatation and decreased connexin-40
expression associated with decreased conduction
velocity [20]. Mice with a RyR2 CPVT mutation
causing increased SR Ca2+ leak and mouse hearts
with acutely elevated intracellular Ca2+ levels also
showed decreased atrial conduction velocity [21].
The underlying mechanisms appear to involve both
acute Ca2+-dependent inhibition of Na+ channels
and chronic downregulation of Nav1.5 expression
[22]. Most importantly, normalization of the RyR2-
mediatedCa2+ leak inCREM-TGmice prevented the
development of both atrial dilatation and conduc-
tion velocity reduction [20]. This suggests that
RyR2-mediated SR Ca2+ leak may drive AF progres-
sion via these and possibly other remodelling path-
ways, thereby potentially contributing to AF
maintenancebystructural remodellingand reentry.
Finally, right atrial cardiomyocytes from patients
with paroxysmal AF, who had been in sinus
rhythm at the time of tissue procurement for
several weeks, also exhibited an increased inci-
dence of DADs and cellular triggered activity [18].
The underlying molecular substrate involves
increased SR Ca2+ load and RyR2 dysregulation,
with the latter resulting from increased protein
expression and higher single-channel open proba-
bility. A relative deficiency of the RyR2-stabilizing
protein junctophilin-2, due to increased RyR2 but
unaltered junctophilin-2 expression, might explain
the RyR2 dysfunction, although the precise mech-
anisms of SR Ca2+ leak in patients with paroxysmal
AF are still incompletely understood. Further work
is needed to delineate the molecular mechanisms
of increased cellular triggered activity in patients
with paroxysmal AF and to determine whether
these cellular events contribute to initiation and
recurrence of AF episodes in these patients.
AF-induced structural remodelling versus primary atrial
cardiomyopathy
Despite years of research and advances in cathe-
ter-based therapies for AF, we are still striving to
understand the reasons for the development of AF
and the mechanisms underlying the structural
abnormalities in atrial walls observed in patients
with the arrhythmia. The common perception that
AF is the result of interplay between the structural
changes in the atrial myocardium induced by the
well-described cardiovascular disease risk factors
and structural remodelling induced by the arrhyth-
mia itself has recently been challenged by obser-
vations of progressive structural abnormalities in
the atrial walls that occur independently from the
cardiovascular comorbidities and persistency of AF
[23]. However to what extent this fibrotic atrial
cardiomyopathy represents a ‘common cause’ of AF
or a mechanism responsible for arrhythmia devel-
opment in a subgroup of patients with AF pheno-
type remains uncertain.
One of the first observations that challenged the
causative relationshipbetweenAFanddevelopment
of atrial fibrosis came from an experimental study
demonstrating that atrial pacing-induced AF per se
did not result in any detectable fibrosis develop-
ment, whereas induction of congestive heart failure
was associated with AF inducibility and led to
significant fibrotic transformation of atrial myocar-
dium [24]. In humans, an indirect indication of the
link between cardiovascular comorbidities and AF
comes from epidemiological studies, in which
potentially fibrosis-causing conditions such as
hypertension, ischaemic heart disease and diabetes
are highly predictive of incident AF [25]. An age-
related increase in the prevalence of AF has also
been well-documented [26] and explained by grow-
ing cardiovascular disease burden in the elderly as
well as an age-related increase in the extent of atrial
fibrosis [27]. However, attempts to provide a quan-
titative assessment of atrial structural abnormali-
ties associated with AF have demonstrated a more
complex picture. Even though catheter-based tech-
niques of endocardial voltage mapping and emerg-
ing noninvasive MRI have been valuable for
visualization of atrial structural abnormalities, his-
tological evaluation of atrial tissue samples remains
the gold standard for tissue characterization. This
approach, however, is often limited to a small
volume of tissue samples that can be collected in
patients undergoing atrial biopsy or confined to
right or left atrial appendages in patients undergo-
ing open-chest heart surgery, thus imposing a
significant bias on patient selection and leaving
large portions of atrial walls, in which AF perpetu-
ates, unattainable.
In a postmortem study that included atrial tissue
samples collected from multiple locations in the
right and left atria in patients with paroxysmal AF,
permanent AF or no history of AF in a 1: 1: 1
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fashion according to prespecified inclusion criteria
[28], the extent of fibrosis and fatty tissue in the
atrial myocardium showed strong and significant
correlation with the presence of AF at all tissue
sampling locations in the left and right atria (see
examples in Fig. 2). Notably, patients with and
without AF did not differ in regard to cardiovascu-
lar comorbidities and no age-related increase in the
extent of atrial fibrosis was evident. Similar obser-
vations were made in patients with persistent or
long-standing AF referred for surgical ablation [29],
thus suggesting that development of structural
abnormalities in the atria is not a result of
concomitant diseases but rather a phenomenon
associated with AF. Indirect assessment of atrial
fibrosis using MRI in a large cohort has further
supported this theory as no significant differences
in the estimated extent of fibrosis between AF
patients with and without comorbidities were
found [30]. To our knowledge, however, no histo-
logical studies have been conducted to specifically
address the issue of causal relationships between
the burden of concomitant cardiovascular diseases
and atrial fibrosis in patients with AF.
However, whether or not structural abnormalities
observed in the atria are the cause or consequence
of AF remains unclear. Indeed, the presence of a
relationship between the extent of fibrosis and AF
burden could be explained in one of two ways:
extensive fibrosis in the atria may promote persis-
tent AF or may be a consequence of the long-
standing fibrillatory process. The lack of this
relationship, however, would favour the concept
that the primary fibrotic atrial cardiomyopathy
underlies AF development. Available data suggest
that the extent of fibrosis tends to be higher in
patients with permanent AF compared with those
with paroxysmal AF [28] but the relationship
between the extent of structural abnormalities
and duration of AF seems to disappear in patients
with persistent AF [29]. In another study in which
the expression of extracelluar matrix proteins in
atrial tissue samples collected during heart surgery
was quantified, no systematic differences between
patients with paroxysmal and permanent AF were
observed [31]. Even though this does not address
the unresolved causality issue, it could be specu-
lated that the extent of fibrosis in the atrial walls
may be linked to AF burden and clinical manifes-
tations of the arrhythmia at the early stages of the
disease but upon reaching a certain level would no
longer affect AF phenotype in patients who develop
persistent AF.
Long-term observational studies would be able to
resolve this controversy if they were able to show
that successful rhythm-control intervention slows
or abolishes progression of the atrial structural
changes; however, direct histological evidence of
this cause–effect relationship is lacking at present.
By contrast, the first proof of progressive atrial
Fig. 2 Light microscopy of
crista terminalis specimens
from patients without a history
of atrial fibrillation (AF) (left)
and with permanent AF (right).
Note the widespread interstitial
fibrosis and disruption of
myocardial bundles in the
permanent AF specimen.
Masson’s trichrome stain;
original magnification 9200.
Courtesy of Dr. Lubov
Mitrofanova.
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remodelling after successful catheter ablation was
reported from a small cohort study of patients who
demonstrated a further decrease in atrial electro-
gram voltage and further slowing of atrial conduc-
tion velocity 1 year after pulmonary vein isolation
[32]. To what extent these findings can be gener-
alized to a larger population of patients with AF
remains to be investigated.
Table 1 provides an overview of the most relevant
pathophysiological alterations associated with or
predisposing to AF.
Multiple wavelet hypothesis versus rotors
Another central topic of debate is the analysis and
interpretation of electrograms during AF. Defining
the sequence of activation during AF is fundamen-
tal to the understanding of the pathophysiology of
AF. The current diversity in the perception of
different mechanisms sustaining AF is partly due
to the fact that no consensus has been achieved so
far with regards to minimal requirements for elec-
trogram recordings and analysis or the interpreta-
tion of electrograms during AF.
Table 1 Overview of the most important structural alterations in atrial tissue associated with or predisposing to atrial
fibrillation (AF)
Structural/biochemical alteration Functional consequence
Key
references
Alterations
promoting
conduction
disturbances
and reentry
Interstitial and replacement fibrosis Electrical dissociation, conduction
block, macro-reentry
[27, 48, 49]
Endomysial fibrosis related to AF Electrical dissociation, high AF
complexity, micro-reentry, endo-
epicardial dissociation
[50, 51]
Inflammatory infiltration Induction of profibrotic responses [52]
Fatty infiltration Induction of profibrotic and
pro-inflammatory reactions,
conduction disturbances
[53, 54]
Amyloidosis Conduction disturbances [55, 56]
Gap junction alterations Conduction disturbances [57]
Myocyte hypertrophy Aggravation of conduction
disturbances
[58]
Apoptosis/myocyte death Induction of profibrotic alterations [24]
Ion channel
remodelling
AF cycle length shortening (if due to atrial
tachycardia), AF cycle length prolongation
(if due to heart failure), enhanced
heterogeneity of atrial repolarization
Variable changes in wavelength,
enhanced heterogeneity of atrial
refractoriness
[17, 59, 60]
Changes inducing/
promoting ectopy
Ca2+-handling instability Increased propensity to ectopy [9, 12–15]
Sympathetic hyperinnervation Enhanced release of catecholamines,
enhanced propensity to ectopy
[61, 62]
Vascular and
prothrombotic
alterations
Microvascular rarefaction Aggravation of atrial ischaemia,
heterogeneity of electrical function,
structural remodelling
[63]
Endocardial remodelling Enhanced risk of thrombus formation [64]
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Traditionally, AF was thought to be sustained by
multiple wavelets, as proposed by Moe in the late
1950s [33]. According to this hypothesis, continu-
ous wavefront–wavetail interactions lead to wave-
break and generation of new wavefronts while the
number of fibrillation waves tends to be reduced by
collision and fusion. As long as the number of
fibrillation waves stays above a critical number,
multiple wavelets are able to sustain AF. The
multiple wavelet hypothesis is supported by much
experimental evidence ranging from the initial
observation of numerous independent wavefronts
in canine atria exposed to acetylcholine [34] to the
finding of multiple wavelets in patients with AF
based on ECG imaging [35] and epicardial high-
density mapping in patients undergoing open chest
surgery [36, 37].
Spiral wave reentry or rotors were identified in the
atria more than 90 years ago [38]. In the 1970s
Allessie et al. [39] demonstrated in rabbit atria that
rotating reentry does not require an anatomical
obstacle. More recently, Mandapati et al. [40]
identified rotors driving AF in isolated sheep atria
exposed to acethylcholine. A comparison of mech-
anisms underlying spiral wave reentry and multi-
ple wavelets is shown in Fig. 3.
Recently, several groups have demonstrated rotors
driving AF in humans. Using phase analysis of
endocardial atrial electrograms recorded with a
basket catheter, Narayan et al. [41] demonstrated
rotors in both the right and left atria. Many of these
rotors are detectable for many seconds up to
minutes at the same location [42]. Ablation of the
core of these rotors and focal sources [focal
impulse and rotor modulation (FIRM)] led to termi-
nation of AF in 86% of the patients (72% with
persistent AF and 28% with paroxysmal AF) [41]. In
a more recently published report from a multicen-
tre FIRM registry, single-procedure freedom from
AF after a follow-up of 1 year was approximately
80% and similar in patients with paroxysmal or
persistent AF [43].
Usingacompletelydifferentapproach,Haissaguerre
et al. [44] have also detected rotors. They used ECG
imaging, a technique which allows the reconstruc-
tion of conduction patterns in the heart based on an
array of body surface electrograms and the individ-
ual anatomy of the thorax from thoracic CT or MRI.
This technique shows driver regions consisting of
rotors (80%) and focal breakthroughs (20%). The
driver regionswere not spatially stable but occurred
at preferential sites visualized by an automatically
calculated cumulative source density map. Overall,
70% of the drivers occurred in the left atrium.
Ablation of the drivers resulted in termination of AF
in75%ofpatientswithpersistentAF;85%ofpatients
with persistent AF were still in sinus rhythm after
1 year (comparable to the control group undergoing
stepwise ablation) but the radiofrequency delivery
Fig. 3 (a) Spiral wave reentry. The activation wavefronts turn around a core which represents an anatomical obstacle for
conduction. Typically, the conduction velocity decreases towards the core of rotation because the source–sink mismatch
shifts increasingly towards the sink. The core is unexcited, but excitable, and can migrate through excitable tissue and may
anchor at sites with a short refractory period or enhanced sink (branching points of muscle bundles). (b) Multiple wavelet
reentry. Waves (different grey scales) are separated by multiple lines of conduction block. Asterisks show ‘breakthroughs’
which are due to transmural conduction originating from deeper layers of the atrial wall [three-dimensional substrate for
atrial fibrillation (AF)].
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timewas shortened to less than 50%as compared to
the control group suggesting that targeting rotors
identified by ECG imaging is a very effective inter-
vention to destabilize AF.
Despite the very promising results presented from
studies targeting rotors for ablation of AF, many
questions essential to the understanding of the role
of rotors in AF and of the mechanisms of AF in
general remain unanswered. First, it is clear that
detection of rotors using basket mapping data and
FIRM provides fundamentally different results
regarding the spatial behaviour of rotors as com-
pared to ECG imaging. Whereas FIRM demon-
strates spatially stable rotors with hundreds of
revolutions taking place at one specific site, ECG
imaging as conducted by Haisssaguere et al. shows
that the reentrant circuits are not spatially stable
but migrate throughout the atrium. Nevertheless,
they occur preferentially at specific sites that may
provide a target for ablation. The reason for this
significant discrepancy between the spatial beha-
viour of rotors identified by these different tech-
niques is currently unclear.
A very striking distinction between thenewmapping
techniques and direct contact mapping is the huge
difference in complexity. While ECG imaging can
detect between two and 10 simultaneous fibrillation
waves in patients with persistent AF [35], the
number of simultaneous waves identified by direct
contact mapping is 0.5 per cm2 which is equivalent
to at least 100 simultaneous waves in total [37]. It is
possible that the considerable difference in AF
complexity between FIRM and ECG imaging on the
one hand and direct contactmapping on the other is
related to preprocessing of the electrograms. Both
ECG imaging and basket mapping use phase anal-
ysis to determine rotational conduction behaviour
during AF. A repetitive phenomenon is described by
phase analysis not as its actual state as a function of
time but by its phase within a repetitive cycle. A
classical example is time, commonly measured as
time after midnight. Phase analysis can be per-
formed on signals that show a high degree of
periodicity andamonophasic shape. Phase analysis
has been used for monophasic or optical action
potential data or for ventricular electrograms which
show a more regular and monophasic shape. Atrial
electrograms show a high degree of fractionation
and therefore need to be preprocessed to allow for a
meaningful analysis of phase [45]. This preprocess-
ing must contain a strong element of spatial or
temporal filtering and smoothing so that fractiona-
tion is fully removed from the signals. It is currently
unclear how far thismassive prefiltering step affects
the conduction pattern determined by these tech-
niques but it is reasonable to assume that any
smoothing and major filtering will reduce the
detected complexity of AF.
Finally, the relation between the identified conduc-
tion patterns and the anatomy of the atrium has not
been addressed in detail in studies using FIRM. The
use of high-density direct contact mapping has
provided evidence that the anatomy of endocardial
atrial trabeculae and muscle bundles as well as the
fibre orientation in the epicardial layer constitute
important determinants of direction and preferen-
tiality of fibrillation waves [46], however, no such
data have been provided using FIRM. The spatial
distribution of the identified sources of AF has been
described but the location of important anatomical
structures such as the pulmonary veins is often not
included in the graphical depictions or movies
showing stable rotors identified by basket mapping.
Thus, relevant issues remain to be addressed, such
aswhether thestability of someof the reported rotors
is related to reentry around the pulmonary veins.
Unfortunately, many details of the algorithms used
for the analysis of ECG imaging and for FIRM have
not been disclosed. Investigators studying AF con-
duction patterns by direct contact mapping have
provided detailed information on assumptions,
definitions and algorithms of the quantitative
parameters used [36, 37, 45, 47], but such
description is largely lacking in the case of ECG
imaging and FIRM. It is clear that in these cases
the economic interests of the intellectual property
holders of these techniques compete with the
principle of transparency of scientific research
and the culture of sharing methods and results
within the scientific community.
A plea for transparency in translational electrophysiology
The translation of data from basic science and
animal studies into clinical practice is one of the
most important goals of medical research and the
foundation of intense research interest. The con-
siderable expense associated with basic and exper-
imental research and the required extensive
funding may at last receive social justification if
this research finally leads to a transfer of knowl-
edge to clinical medicine and, thereby, to a recog-
nizable improvement of patient care. Extensive
exchange and cooperation between basic research
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scientists and clinicians is essential for the pro-
motion of this translational process. Subsequently,
rapid translation is crucial to achieve wider appli-
cation and thus easier confirmation and reproduc-
tion of results derived from implementation of novel
methods and technologies. An open approach with
extensive disclosure of research data and of techni-
cal details is not only undoubtedly an ethically
superior approach, but is also beneficial for clinical
scientists as this is the fastest way for wide accep-
tance of novel ideas and ultimately for scientific
recognition of research work. Financial considera-
tions of possible benefits deriving for example from
patented algorithms or techniques may impose
barriers to such an open approach. However, the
current practice of very successful large corpora-
tions exhibiting astonishing openness in this con-
text may serve as an example that this openness is
not necessarily disadvantageous. We believe that it
is essential that all stakeholders in the field, includ-
ing scientists and business developers as well the
editors of major scientific journals, recognize their
particular responsibility to promote open and reli-
able access to scientific data for the successful
future of basic and clinical science.
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